Q3 2024 Earnings Conference Call October 17, 2024 11:00 AM ETCompany ParticipantsKaren Bauer - VP of IR, Corporate ...
Findings suggest the potential for obe-cel treatment without the need for consolidative SCTObe-cel given as a sole treatment to patients with lower tumor burden at lymphodepletion was associated with ...
We have on the call, Nick Pinchuk, Snap-on's Chief Executive Officer; and Aldo Pagliari ... the forward-looking statements are contained in our SEC filings. Finally, this presentation includes ...